Growth Hormone & Secretagogues

CJC-1295 & IPAMORELIN BLEND

Research Use Only
Purity
99% (Each Peptide)
CAS Number
Blend – Not Applicable
Molecular Weight
See specifications
Storage
2–8°C (36–46°F)
Zurich Rx research vial with red cap
CJC-1295 + IPAMORELIN

Compound Overview

CJC-1295 & Ipamorelin Blend is a research formulation combining two well-characterized investigational peptides: CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), and Ipamorelin, a highly selective growth hormone secretagogue receptor (GHSR-1a) agonist. Together, these peptides provide researchers with a valuable experimental model for investigating complementary endocrine signaling pathways involved in growth hormone regulation and peptide pharmacology.

CJC-1295 has been extensively studied for its ability to selectively activate the GHRH receptor and promote prolonged endocrine signaling, while Ipamorelin has been investigated for its selective interaction with the ghrelin (GHSR-1a) receptor. The combination enables researchers to examine the coordinated activity of two distinct physiological pathways governing growth hormone secretion, receptor signaling, intracellular communication, and peptide pharmacokinetics.

As an investigational research formulation, the CJC-1295 & Ipamorelin Blend supports laboratory studies involving endocrine physiology, receptor biology, peptide engineering, molecular signaling, and structure-activity relationships.

Research Applications

Growth hormone-releasing hormone (GHRH) receptor pharmacology Growth hormone secretagogue receptor (GHSR-1a) signaling Endocrine physiology Cellular signaling pathways Peptide pharmacology Receptor interaction studies Peptide pharmacokinetics Structure-activity relationship (SAR) research Hormonal signaling investigations Animal model research

Research applications are presented for educational and informational purposes only and do not imply approved therapeutic uses.

Product Specifications

Purity99% (Each Peptide)
AppearanceWhite to Off-White Lyophilized Powder
CompositionCJC-1295 + Ipamorelin
Blend RatioInquire
StorageStore refrigerated at 2–8°C (36–46°F). For extended laboratory storage, maintain at −20°C or below. Protect from moisture and light.
CAS NumberBlend – Not Applicable
Research GradeLaboratory Research Use Only

Available Sizes

10 mg

Pricing: Inquire — contact our team for current pricing and availability.

Product Documentation

COA
HPLC Report
Mass Spec
Purity Data
Request documentation for your exact lot

Every batch of CJC-1295 & IPAMORELIN BLEND is independently tested and assigned its own lot number. When you request documentation, include the product name and lot number printed on your vial so we can send the COA, HPLC, and MS data specific to the batch in your hand — not a generic reference sample. Request documentation →

Laboratory Handling

Store refrigerated immediately upon receipt to preserve peptide stability. For extended laboratory storage, freezing at −20°C or below is recommended. Protect the lyophilized peptide blend from moisture, excessive heat, and direct light. Avoid repeated freeze-thaw cycles following reconstitution, as these may reduce peptide integrity. Allow the vial to equilibrate to room temperature before opening to minimize condensation, and always use sterile laboratory equipment together with appropriate aseptic laboratory techniques. This product is intended for use only by qualified research personnel operating in controlled laboratory environments.

Selected Scientific Literature

  1. Teichman SL, Neale A, Lawrence B, et al. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor-I Following a Single Injection of CJC-1295 in Healthy Adults. Journal of Clinical Endocrinology & Metabolism.
  2. Jette L, Leger R, Thibaudeau K, et al. Human Growth Hormone-Releasing Factor Coupled to Drug Affinity Complex (DAC®) Technology Generates a Long-Acting GHRH Analog. Journal of Controlled Release.
  3. Raun K, Hansen BS, Johansen PB, et al. Ipamorelin, the First Selective Growth Hormone Secretagogue. European Journal of Endocrinology.
  4. Smith RG, Van der Ploeg LHT, Howard AD, et al. Peptidomimetic Regulation of Growth Hormone Secretion Through the Growth Hormone Secretagogue Receptor. Endocrine Reviews.
Research Use Only (RUO)

This product is intended exclusively for laboratory research. It is not intended for human consumption, therapeutic use, diagnostic procedures, or veterinary applications. Zurich Rx supplies research materials solely for scientific investigation; researchers are responsible for ensuring products are handled and used in accordance with applicable laws and institutional policies. See our full RUO disclaimer.

Compare with related compounds

Other compounds researchers commonly browse alongside CJC-1295 & IPAMORELIN BLEND in Growth Hormone & Secretagogues.

CompoundPurityMolecular WeightCAS Number
CJC-1295 & IPAMORELIN BLEND99% (Each Peptide)Blend – Not Applicable
IPAMORELIN99%711.85 g/mol170851-70-4
CJC-1295 (No DAC)99%3,364.0 g/mol86168-78-7 (Modified GRF (1-29))
CJC-1295 (DAC)99%3,364.90 g/mol863288-34-0
IGF-1 LR3 (LONG R3 INSULIN-LIKE GROWTH FACTOR-1)99%9,203.3 g/mol946870-92-4

Need a Certificate of Analysis?

Request COAs, HPLC, or MS documentation for CJC-1295 & IPAMORELIN BLEND.

Request Pricing